Lyvgen Biopharma
Biotechnology, 2317 Hastings Dr, shanghai, California, 94002, United States, 51-200 Employees
Who is LYVGEN BIOPHARMA
Lyvgen is a biopharmaceutical company focused on developing novel therapies for cancer. Lyvgens xLinkAbTM functional platform creates agonist antibodies (Abs) with tumor-localized immunos...
Read More
-
Headquarters: 2317 Hastings Dr, shanghai, California, 94002, United States
-
Date Founded: 2016
-
Employees: 51-200
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
-
CEO:
Jieyi Wang
Email
Phone
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from LYVGEN BIOPHARMA
Lyvgen Biopharma Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Lyvgen Biopharma
Answer: Lyvgen Biopharma's headquarters are located at 2317 Hastings Dr, shanghai, California, 94002, United States
Answer: Lyvgen Biopharma's official website is https://lyvgen.com
Answer: Lyvgen Biopharma's revenue is Under $1 Million
Answer: Lyvgen Biopharma's SIC: 2834
Answer: Lyvgen Biopharma's NAICS: 325412
Answer: Lyvgen Biopharma has 51-200 employees
Answer: Lyvgen Biopharma is in Biotechnology
Answer: Lyvgen Biopharma contact info: Phone number: Website: https://lyvgen.com
Answer: Lyvgen is a biopharmaceutical company focused on developing novel therapies for cancer. Lyvgens xLinkAbTM functional platform creates agonist antibodies (Abs) with tumor-localized immunostimulatory activities by balancing multiple functions of candidate Abs. Lyvgens most advanced programs include LVGN6051, a monoclonal antibody (mAb) agonist for CD137/4-1BB, LVGN7409, a mAb agonist for CD40, LVGN1673, a bispecific antibody (BsAb) blocking PD-L1 and trapping TGF1/2/3, and anti-PD-1 blocking antibody LVGN3616. Lyvgen has initiated Phase I clinical trial of LVGN6051 alone or in combination with anti-PD-1 antibody in the USA. Lyvgen plans to start Phase I testing of LVGN6051 in China, LVGN7409 and LVGN1673 globally. Lyvgen employs over 35 scientists with global pharmaceutical research and development experiences at its research sites in China and the USA.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month